{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-21-126794","form_type":"8-K","ticker":"PTPI","cik":"0001815903","company_name":"Petros Pharmaceuticals, Inc.","filed_at":"2021-10-15T23:59:59+00:00","discovered_at":"2026-05-14T18:04:14.283182+00:00","generated_at":"2026-06-28T20:37:22.257331+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Petros Pharmaceuticals raises ~$5.7M in registered direct offering led by largest shareholder","bullets":["Offering of 3,323,616 shares at $1.715 per share; warrants for same number at same price, 5-year term.","Gross proceeds ~$5.7M; net proceeds ~$5.4M after fees; expected close Oct 18, 2021.","Proceeds will fund expansion of men's health platform and general corporate purposes.","Katalyst Securities served as financial advisor; advisory fee and expenses $235,000 plus 130,000 warrants.","Largest shareholder led the offering; warrants issued in private placement, unregistered."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-21-126794","json":"https://secwatch.observer/filing/0001104659-21-126794.json","markdown":"https://secwatch.observer/filing/0001104659-21-126794.md","text":"https://secwatch.observer/filing/0001104659-21-126794.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1815903/000110465921126794/0001104659-21-126794-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1815903/000110465921126794/tm2130098d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T20:37:22.257331+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}